Global anti-HA Antibody Market Growth 2018-2023

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry. In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China According to this study, over the next five years the anti-HA Antibody market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in anti-HA Antibody business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of anti-HA Antibody market by product ...
Table of Contents 2018-2023 Global anti-HA Antibody Consumption Market Report 1 Scope of the Report 1.1 Market Introduction 1.2 Research Objectives 1.3 Years Considered 1.4 Market Research Methodology 1.5 Economic Indicators 1.6 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global anti-HA Antibody Consumption 2013-2023 2.1.2 anti-HA Antibody Consumption CAGR by Region 2.2 anti-HA Antibody Segment by Type 2.2.1 IgM 2.2.2 IgG 2.2.3 IgA 2.2.4 Other 2.3 anti-HA Antibody Consumption by Type 2.3.1 Global anti-HA Antibody Consumption Market Share by Type (2013-2018) 2.3.2 Global anti-HA Antibody Revenue and Market Share by Type (2013-2018) 2.3.3 Global anti-HA Antibody Sale Price by Type (2013-2018) 2.4 anti-HA Antibody Segment by Application 2.4.1 Therapeutic 2.4.2 Research 2.4.3 Diagnostic 2.5 anti-HA Antibody Consumption by ...
1404

7378

OUR CLIENT